N	Concordance
1	      refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented  
2	I or contiguous stage II aggressive non-Hodgkin's lymphoma (NHL).   Radiation th
3	derived chemotherapy for aggressive non-Hodgkin's lymphoma in two general hospit
4	rome).    Other types of aggressive non-Hodgkin's lymphoma are anaplastic large-
5	Pathologically confirmed aggressive non-Hodgkin's lymphoma of any stage    Posit
6	        The prognosis of aggressive non-Hodgkin's lymphoma (NHL) has improved gr
7	HIV, as is the  case for aggressive non-Hodgkin's lymphoma.  The CDC, in conjunc
8	 For which patients with aggressive non-Hodgkin's lymphoma is prophylaxis       
9	cally proven indolent or aggressive non-Hodgkin's lymphoma (except   lymphoblast
10	erly       paitents with aggressive non-Hodgkin's lymphoma should be considered 
11	 not seen in any case of aggressive non-Hodgkin's lymphoma with an intact p53 pa